Table 5.

Log hormone levels and HOMA-IR in HIV-infected participants^*

	FT Model β (p)	FT Model β (p)	FT Model: AM ONLY β (p)	SHBG Model β (p)	SHBG Model: AM ONLY β (p)
Log hormone**	−0.12 (0.04)	−0.08 (0.20)	−.14 (0.09)	−0.13 (0.03)	−.12 (0.11)
Age	0.00 (0.40)	0.00 (0.90)	−.01 (0.35)	0.00 (0.67)	.00 (0.73)
Race (Black v. other)	−0.06 (0.42)	−0.03 (0.73)	−.10 (0.31)	0.00 (0.99)	−.07 (0.47)
Current CD4 ≥ 200	0.03 (0.79)	0.01 (0.95)	−.07 (0.59)	−0.03 (0.79)	−.12 (0.36)
BMI	0.05 (<0.001)	0.01 (0.26)	0.02 (0.17)	0.01 (0.38)	0.02 (0.26)
HCV-infected	0.28 (<0.01)	0.25 (0.01)	0.22 (0.06)	0.31 (0.001)	0.27 (0.02)
Viral load ≥ 400	−0.09 (0.17)	−0.13 (0.05)	−.15 (0.08)	−0.13 (0.06)	−.15 (0.08)
Ever stavudine therapy	0.26 (<0.001)	0.28 (<0.001)	0.29 (<0.001)	0.28 (<0.001)	0.29 (<0.001)
Waist circumference	--	0.02 (<0.01)	0.01 (0.03)	0.02 (<0.01)	0.01 (0.02)

^*All models adjusted for log hormone, age, site, black race, BMI, HCV status, CD4, viral load, ever used d4T, and waist circumference, unless marked with --.

^**Odds ratio or β corresponds to each 1-log increase in either FT or SHBG